Global Expansion PackGene has established a multi-regional footprint with offices in Boston, Houston, and Zurich, plus a U.S. CDMO facility and a China-U.S.-Europe network. This presents cross-border collaboration opportunities and regional servicing for global gene therapy programs, especially for early R&D through IND studies.

Integrated Services Positioning as a one-stop solution provider for gene therapy including plasmid, viral vector, fill-finish, and QC analytics creates upsell potential to clients seeking streamlined supply chains and faster time-to-IND through bundled offerings.

Clinical & Timing Active engagement in presenting at ASGCT and ongoing advancements in scalable AAV manufacturing and analytical characterization indicate readiness to support programs advancing toward clinical trials, opening opportunities with sponsors needing robust CDMO support.

Recognition & Trust Awards for technology innovation leadership and global innovator status enhance credibility with potential customers and partners seeking proven CRDMO capabilities, particularly in AAV vector development and manufacturing.

Strategic Partnerships Recent integration with research institutes (example CMRI collaboration) signals appetite for joint development and material supply arrangements, suggesting sales avenues in co-development, technology licensing, and materials partnerships to expand service adoption.